Search - tctmd.com

Displaying 941 - 960 of 3850

Sort: Relevancy | Date

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Conference News HFSA 2022

Dapagliflozin’s Benefits Similar in HF Patients With Improved EF: DELIVER

Todd Neale

October 04, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Daily News

Another DOAC Fails in the Setting of Mechanical Heart Valves

Todd Neale

September 28, 2022

News Daily News

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

Todd Neale

September 26, 2022

News Daily News

mRNA Vaccine-Linked Myocarditis Resolves in Time, Without Clinical Events

Michael O'Riordan

September 26, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

Anticoagulation for PE: When to Switch to DOACs?

Presenter: Behnood Bikdeli

September 19, 2022

Presentation TCT 2022

EXpansion of Stents After Intravascular lithoTripsy vs Conventional Predilatation in CALCified Coronary Arteries

Presenter: Maarten Vink

September 19, 2022

Presentation TCT 2022

Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial

Presenter: Rania Hammami

September 19, 2022

Presentation TCT 2022

Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Presenter: Shamir Mehta

September 19, 2022

Presentation TCT 2022

Survival After PCI or CABG for Left Main Coronary Disease: A Report From the Swedish Coronary Angiography and Angioplasty Registry

Presenter: Elmir Omerovic

September 19, 2022

Presentation TCT 2022

The Importance of Addressing Lipids in Patients With Complex PCI

Presenter: Nisha Jhalani

September 19, 2022

Presentation TCT 2022

CDT: New Devices, Drugs, and Duration?

Presenter: Andrew Sharp

September 19, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

First Safety and Efficacy Study of the Misago Stent in Lower Extremity Endovascular Interventions via Radial Access Approach

Presenter: Yulanka Castro

September 17, 2022

Advertisement

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Dapagliflozin’s Benefits Similar in HF Patients With Improved EF: DELIVER

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

October 2022 News Roundup

Another DOAC Fails in the Setting of Mechanical Heart Valves

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

mRNA Vaccine-Linked Myocarditis Resolves in Time, Without Clinical Events

Most Patient-Reported Outcome Measures in CVD Fall Short

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Anticoagulation for PE: When to Switch to DOACs?

EXpansion of Stents After Intravascular lithoTripsy vs Conventional Predilatation in CALCified Coronary Arteries

Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial

Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Survival After PCI or CABG for Left Main Coronary Disease: A Report From the Swedish Coronary Angiography and Angioplasty Registry

The Importance of Addressing Lipids in Patients With Complex PCI

CDT: New Devices, Drugs, and Duration?

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

First Safety and Efficacy Study of the Misago Stent in Lower Extremity Endovascular Interventions via Radial Access Approach

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content